Prev Arrow Stocks

Chemours Company (The) ($CC) Stock Forecast: Up 5.0% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Chemours Company (The)?

Chemours (CC) is a specialty chemicals company that recently reached a new 52-week high at $26.98.

Why is Chemours Company (The) going up?

CC stock is up 5.0% on Apr 30, 2026 18:21

  • The significant stock price appreciation of Chemours (CC) can be attributed to multiple factors:
  • Despite differing views on its valuation, the stock has experienced a surge in price, indicating investor confidence in its future.
  • Investments by Vanguard Capital Management and Vanguard Portfolio Management have further bolstered faith in the company's growth.
  • The recent peak in stock price reflects positive momentum and investor attraction towards Chemours.
  • Concerns raised by Cumberland County about PFAS contamination pose potential risks for Chemours, potentially affecting its future stock performance.

CC Price Chart

CC Technical Analysis

CC News

Assessing Chemours (CC) Valuation After A Strong Multi‑Period Share Price Run

Chemours (CC) has seen significant stock price appreciation recently, with shares up over 24% in the last month and over 115% year-to-date. Despite this surge and a current price of $26.34 against an analyst target of $22.67, Simply Wall St's analysis suggests the stock is overvalued, with a fair value of $16.33, primarily due to future earnings potential and lingering legal risks. However, another view based on multiples suggests a 55.3% discount to intrinsic value, highlighting a split in valuation perspectives due to recent returns and unresolved risks.

https://simplywall.st/stocks/us/materials/nyse-cc/chemours/news/assessing-chemours-cc-valuation-after-a-strong-multiperiod-s

0 News Article Image Assessing Chemours (CC) Valuation After A Strong Multi‑Period Share Price Run

Vanguard Capital Management (CC) reports 7.9M shares; 5.26% holding

Vanguard Capital Management has filed a Schedule 13G, disclosing a passive beneficial ownership of 7,903,519 shares of Chemours Co/The (CC), which represents 5.26% of the company's common stock. The filing also indicates that Vanguard has sole dispositive power over all these shares and sole voting power over 1,129,602 shares. This standard disclosure signifies Vanguard's significant but passive investment in Chemours.

https://www.stocktitan.net/sec-filings/CC/schedule-13g-chemours-co-passive-investment-disclosure-5-0734bf4087b3.html

1 News Article Image Vanguard Capital Management (CC) reports 7.9M shares; 5.26% holding

Vanguard Portfolio Management reports 10.46M Chemours shares (CC)

Vanguard Portfolio Management has reported beneficial ownership of 10,456,302 shares of Chemours Co (CC) Common Stock as of March 31, 2026, representing 6.96% of the class. This disclosure, made via a Schedule 13G filing signed on April 29, 2026, by Ashley Grim, Head of Global Fund Administration, indicates sole voting power over 130,961 shares and sole dispositive power over all 10,456,302 shares. The shares are held for Vanguard funds and managed accounts, with the filing emphasizing that they were acquired in the ordinary course of business for investment purposes rather than to influence control.

https://www.stocktitan.net/sec-filings/CC/schedule-13g-chemours-co-passive-investment-disclosure-5-3cca36195f9a.html

2 News Article Image Vanguard Portfolio Management reports 10.46M Chemours shares (CC)

The Chemours Co. Hits New 52-Week High at $26.98

The Chemours Co. reached a new 52-week high of $26.98 on April 27, 2026, marking a significant increase from its previous low of $9.13. Despite this growth, its year-over-year performance of 10.66% lags behind the S&P 500's 29.84%. The specialty chemicals company currently operates at a loss, as indicated by a negative return on equity, and has a market capitalization of USD 3,138 million with a dividend yield of 1.67%.

https://www.marketsmojo.com/news/stocks-in-action/the-chemours-co-hits-new-52-week-high-at-2698-3966941

3 News Article Image The Chemours Co. Hits New 52-Week High at $26.98

Cumberland Wants State to Make Chemours Fix Filters, Pay for Public Water

Cumberland County commissioners are urging North Carolina regulators to compel Chemours to adequately address PFAS contamination in Gray's Creek residents' drinking water. They claim Chemours has failed to submit a corrective action plan and properly maintain water filter systems, leading to bacterial growth. The county is also investing in extending public water service to the affected community and wants clarity on Chemours' financial obligations for public water connections and monthly bills.

https://www.cityviewnc.com/stories/cumberland-wants-state-to-make-chemours-fix-filters-pay-for-public-water/

4 News Article Image Cumberland Wants State to Make Chemours Fix Filters, Pay for Public Water

Chemours Company (The) Price History

10.03.2026 - CC Stock was up 5.4%

  • Chemours (CC) experienced a strong bullish movement today due to an increased target price and maintained Buy rating by a leading financial institution. This positive outlook reflects confidence in the company's growth potential.
  • The high-performance fluoropolymers (HPF) market is projected to grow, potentially benefiting Chemours given its presence in industrial chemicals, including components for aerospace and automotive industries.
  • Despite the positive forecast and price target increase, Chemours reported a negative net margin and a year-over-year revenue decline, suggesting possible challenges ahead despite the bullish market movement.
  • Ongoing discussions by the EU chemicals agency regarding PFAS chemicals could have implications for Chemours in the future, underscoring regulatory risks in the industry.

30.02.2026 - CC Stock was down 5.1%

  • Despite a recent 5-day winning streak and reaching a new 52-week high, Chemours stock showed strong bearish movement today.
  • Investor profit-taking following the stock's surge in the past few days could explain the bearish pullback.
  • Concerns from analysts regarding the company's weak operational performance, financial state, and high valuation might have influenced the bearish sentiment.
  • The absence of specific positive developments today likely prompted investors to reassess their positions, resulting in the bearish market trend.

08.03.2026 - CC Stock was down 5.8%

  • The bearish movement in CC's stock today could be attributed to concerns surrounding the ongoing lawsuit with the Cape Fear Public Utility Authority over PFAS contamination in drinking water.
  • Despite a company raising its price target on CC and maintaining an "Outperform" rating, the market may be reacting to uncertainties regarding the impact of ultrashort-chain PFAS compounds on the company's operations.
  • The upsizing and pricing of the $700 million senior notes offering by Chemours could have also influenced the bearish sentiment, as investors may be wary of the company's increased debt burden.
  • The significant increase in stake by SG Americas Securities LLC signals long-term confidence in Chemours, but the market may be focusing more on the immediate challenges the company is facing with regards to environmental issues and financial decisions.

30.03.2026 - CC Stock was up 5.0%

  • The significant stock price appreciation of Chemours (CC) can be attributed to multiple factors:
  • Despite differing views on its valuation, the stock has experienced a surge in price, indicating investor confidence in its future.
  • Investments by Vanguard Capital Management and Vanguard Portfolio Management have further bolstered faith in the company's growth.
  • The recent peak in stock price reflects positive momentum and investor attraction towards Chemours.
  • Concerns raised by Cumberland County about PFAS contamination pose potential risks for Chemours, potentially affecting its future stock performance.

16.03.2026 - CC Stock was up 5.1%

  • Chemours (CC) reached a new 52-week high of $23.20, trading with high volume and significantly above its moving averages, reflecting robust investor interest and positive market sentiment.
  • The increase in Chemours' stock price can be linked to the company's recent strong financial performance, surpassing EPS expectations, despite having certain mixed fundamentals like negative net margin and P/E ratio.
  • The update about Southeast Ohio water authorities securing funds for PFAS treatment upgrades may have had a positive impact on Chemours, given the company's involvement in producing chemicals and solutions relevant for water treatment processes.
  • Despite being labeled as overvalued by some analysts, there appears to be a positive market outlook on Chemours' future prospects, with institutions like UBS raising their price target and reaffirming a "Buy" rating.

26.02.2026 - CC Stock was up 5.1%

  • Chemours' stock price surged by 10.11% following the completion of a successful debt swap, indicating investor confidence in the company's financial stability and growth prospects.
  • The strategic agreement with SRF Limited to boost the supply of key low GWP products highlights Chemours' commitment to sustainability and meeting market demand, which likely contributed to the positive market sentiment.
  • Despite facing challenges such as high debt levels and legal battles, Chemours' focus on next-generation refrigerants and environmental regulations positions it well for future growth in the chemical industry.
  • The company's engagement in STEM education initiatives showcases its dedication to fostering talent and innovation, creating a positive image that resonates with investors and stakeholders.

09.03.2026 - CC Stock was up 5.6%

  • CC reached a 52-week high at $22.56, marking a 139% increase in the past year, potentially attracting positivity from investors.
  • Mizuho raised CC's price target to $25 from $21, upholding an "Outperform" rating, potentially enhancing investor confidence and influencing the bullish trend.
  • Despite the lawsuit and regulatory challenges, CC's optimistic earnings forecast for 2026 and expected improvements in titanium dioxide EBITDA margins may have outweighed these issues, propelling the stock.
  • The options chain analysis, detailing call and put options expiring in May 2026, possibly signified a bullish outlook among traders, adding momentum to CC's stock.

25.02.2026 - CC Stock was up 5.1%

  • A successful $700 million debt refinancing and insider buying activities have eased financial concerns, fostering a favorable investor sentiment.
  • Price target upgrades from various firms, including UBS and Mizuho, have been influenced by robust quarterly earnings within the specialized solutions segment, contributing to the uptrend in the stock.
  • Despite potential challenges like regulatory scrutiny regarding environmental issues such as PFAS liabilities, Chemours' strategic outlook remains promising due to continuous innovation efforts and substantial order backlogs.
  • An investigation by The Portnoy Law Firm subsequent to disappointing Q4 and full-year 2025 financial results may have initially dampened investor confidence; however, positive developments thereafter appear to have reversed the stock's trajectory.

24.02.2026 - CC Stock was up 6.1%

  • The bullish movement in CC's stock can be attributed to the successful $700 million private sale of senior notes and insider buying, which helped alleviate financial concerns and boost investor confidence.
  • Analyst upgrades and positive outlook on the company's strategic direction, particularly in the thermal and specialized solutions segment, have also contributed to the stock surge.
  • Despite ongoing legal challenges and environmental controversies, including the lawsuit against DuPont and Chemours and opposition to the Fayetteville expansion, the market seems to be focusing more on the company-specific improvements and growth prospects, leading to the bullish momentum in CC's stock.

24.03.2026 - CC Stock was up 5.1%

  • The bullish movement in CC stock today could be attributed to the positive growth outlook for the global fluoropolymer films market, driven by demand in high-performance industries like electronics and automotive.
  • Earth Day petitions urging Chemours to protect the Okefenokee Swamp may have also fueled investor optimism, highlighting the company's dedication to environmental responsibility and sustainability.
  • The forthcoming Q1 financial results announcement on May 5 and the subsequent public webcast on May 6 may be creating anticipation and confidence among investors, contributing to the bullish market activity in CC stock.

23.02.2026 - CC Stock was up 5.0%

  • The North Carolina Supreme Court reviewing a lawsuit against DuPont and Chemours may have introduced legal uncertainties and risks for the company, impacting market sentiment initially.
  • An investigation into potential securities fraud by the Portnoy Law Firm following disappointing financial results likely contributed to CC's stock price decline.
  • The subsequent increase in CC's stock price may be linked to three analyst firms raising their price targets for the company, indicating improved sentiment and potentially attracting more institutional investors.
  • The strong intraday surge and outperformance of the S&P 500 suggest a positive short-term market response to the raised price targets and overall analyst enthusiasm, despite CC's enduring financial challenges and environmental issues.

01.03.2026 - CC Stock was down 5.0%

  • The bearish movement in Chemours stock today could be attributed to profit-taking by investors after the recent 5-day winning spree, where the stock climbed 22%.
  • Concerns may have arisen among investors about potential legal liabilities and future financial impacts on the company due to the news about a potential new lawsuit against Chemours for PFAS contamination in North Carolina.
  • Despite the positive collaboration with the University of Kansas on sustainable cooling technologies, the overall sentiment from analysts describing the stock as "Very Unattractive" due to weak operating performance and high valuation could have also influenced today's bearish market movement.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.